Sunday, November 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· June 18, 2026

Japan Just Raised Interest Rates To A Level Not Seen Since 1995— And The Yen Carry Trade Is Back

View original at finance.yahoo.com
Japan Just Raised Interest Rates To A Level Not Seen Since 1995— And The Yen Carry Trade Is Back Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below…
Opening lines of the source · Yahoo Finance · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The risk of Japan's economy sharply deteriorating due to the Middle East conflict has lessened, thanks to government measures to mitigate high fuel costs and progress in securing alternative energy supplies.

    60% confidence
  • Businesses are passing on rising oil costs at a relatively fast pace, which could lead to higher consumer prices and risks underlying inflation deviating above the BOJ's price target.

    60% confidence
  • The time for decisive action on yen defense is drawing closer, raising expectations of possible currency intervention.

    60% confidence
  • The Middle East conflict poses a bigger threat to Japan's economic growth than inflation, justifying dissent against the rate hike.

    60% confidence
  • Extremely speculative trading is driving the yen's weakness in currency markets.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,997
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,997 facts checked against source5,585 source documents archived
Query this data → isubstrate.com